1YY2 - Header Asymmetric Unit

HEADER ANTITUMOR PROTEIN 23-FEB-05 1YY2

TITLE NMR CONFORMATIONAL ANALYSIS OF LHRH AND ITS ANALOGUES

COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEUPROLIDE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS IS A SYNTHETIC PEPTIDE. THIS SEQUENCE SOURCE 4 DOES NOT OCCUR NATURALLY IN HUMANS. IT IS A MODIFIED SOURCE 5 SEQUENCE OF LHRH.

KEYWDS U-SHAPE LIKE PEPTIDE, ANTITUMOR PROTEIN

EXPDTA SOLUTION NMR

NUMMDL 21

MDLTYP MINIMIZED AVERAGE

AUTHOR G.A.SPYROULIAS,A.ZOMPRA,V.MAGAFA,P.CORDOPATIS

REVDAT 3 24-FEB-09 1YY2 1 VERSN REVDAT 2 07-MAR-06 1YY2 1 SEQRES FORMUL LINK TER REVDAT 2 2 1 CONECT REVDAT 1 21-FEB-06 1YY2 0

JRNL AUTH G.A.SPYROULIAS,A.ZOMPRA,V.MAGAFA,P.CORDOPATIS JRNL TITL NMR CONFORMATIONAL ANALYSIS OF LHRH AND ITS JRNL TITL 2 ANALOGUES JRNL REF TO BE PUBLISHED JRNL REFN

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AMBER 5.0 REMARK 3 AUTHORS : D.A.PEARLMAN, D.A.CASE, W.CALDWELL, W.S.ROSS, REMARK 3 T.E.CHEATHAM, D.M.FERGUSON, G.L.SEIBEL, REMARK 3 U.C.SINGH, P.K.WEINER, P.A.KOLLMAN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE MODELS HAVE BEEN DETERMINED REMARK 3 USING 135 NOE-DERIVED DISTANCE CONSTRAINTS

REMARK 4 REMARK 4 1YY2 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-MAR-05. REMARK 100 THE RCSB ID CODE IS RCSB032056.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2.0MM-3.0MM REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY, 2D NOESY, 1H-13C REMARK 210 HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 400 MHZ REMARK 210 SPECTROMETER MODEL : DPX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.1, XEASY 1.3, DYANA REMARK 210 1.5 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 400 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 21 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES.

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TRP A 3 -158.83 -176.81 REMARK 500 1 SER A 4 111.05 92.71 REMARK 500 2 TRP A 3 -155.79 -176.43 REMARK 500 2 SER A 4 107.57 94.13 REMARK 500 3 TRP A 3 -150.05 -174.52 REMARK 500 3 SER A 4 107.79 86.58 REMARK 500 4 TRP A 3 -156.80 -176.62 REMARK 500 4 SER A 4 109.20 93.78 REMARK 500 5 TRP A 3 -148.07 -174.27 REMARK 500 5 SER A 4 106.74 78.74 REMARK 500 6 TRP A 3 -157.23 -175.88 REMARK 500 6 SER A 4 109.61 95.51 REMARK 500 7 TRP A 3 -156.14 -176.92 REMARK 500 7 SER A 4 109.17 95.21 REMARK 500 8 TRP A 3 -156.32 -176.03 REMARK 500 8 SER A 4 108.70 89.34 REMARK 500 9 TRP A 3 -155.26 -175.79 REMARK 500 9 SER A 4 109.28 93.76 REMARK 500 10 TRP A 3 -151.22 -174.89 REMARK 500 10 SER A 4 108.00 89.97 REMARK 500 11 TRP A 3 -157.10 -175.67 REMARK 500 11 SER A 4 110.07 96.54 REMARK 500 12 TRP A 3 -148.01 -173.96 REMARK 500 12 SER A 4 107.30 84.53 REMARK 500 13 TRP A 3 -155.35 -176.29 REMARK 500 13 SER A 4 110.24 97.62 REMARK 500 14 TRP A 3 -156.07 -177.64 REMARK 500 14 SER A 4 109.54 94.91 REMARK 500 14 ARG A 8 148.79 -172.25 REMARK 500 15 TRP A 3 -153.56 -175.29 REMARK 500 15 SER A 4 107.12 83.90 REMARK 500 16 TRP A 3 -156.44 -176.59 REMARK 500 16 SER A 4 111.07 96.75 REMARK 500 17 TRP A 3 -155.65 -176.06 REMARK 500 17 SER A 4 107.84 85.07 REMARK 500 18 TRP A 3 -153.96 -175.04 REMARK 500 18 SER A 4 107.22 83.15 REMARK 500 19 TRP A 3 -156.50 -179.17 REMARK 500 19 SER A 4 110.60 88.91 REMARK 500 20 TRP A 3 -145.40 -174.45 REMARK 500 20 SER A 4 104.39 73.09 REMARK 500 20 ARG A 8 149.38 -171.95 REMARK 500 21 TRP A 3 -151.89 -178.76 REMARK 500 21 SER A 4 107.89 87.08 REMARK 500 21 ARG A 8 148.44 -174.30 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NEH A 10

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YY1 RELATED DB: PDB

DBREF 1YY2 A 1 9 PDB 1YY2 1YY2 1 9

SEQRES 1 A 9 PCA HIS TRP SER TYR DLE LEU ARG PRO

MODRES 1YY2 PCA A 1 GLU PYROGLUTAMIC ACID

HET PCA A 1 14 HET DLE A 6 19 HET NEH A 10 9

HETNAM PCA PYROGLUTAMIC ACID HETNAM DLE D-LEUCINE HETNAM NEH ETHANAMINE

FORMUL 1 PCA C5 H7 N O3 FORMUL 1 DLE C6 H13 N O2 FORMUL 2 NEH C2 H7 N

LINK C PCA A 1 N HIS A 2 1555 1555 1.33 LINK C TYR A 5 N DLE A 6 1555 1555 1.33 LINK C DLE A 6 N LEU A 7 1555 1555 1.33 LINK C PRO A 9 N NEH A 10 1555 1555 1.34

SITE 1 AC1 4 TRP A 3 SER A 4 ARG A 8 PRO A 9

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000